1	LONDON	london	NNP	_	6	npadvmod	_
2	,	,	,	_	6	punct	_
3	May	may	NNP	_	6	npadvmod	_
4	19	0	CD	_	3	num	_
5	(	(	-LRB-	_	6	punct	_
6	Reuters	reuters	NNP	_	13	dep	_
7	)	)	-RRB-	_	6	punct	_
8	-	-	:	p2=,	13	punct	_
9	Britain	britain	NNP	_	12	poss	_
10	's	's	POS	_	9	possessive	_
11	top	top	JJ	_	12	amod	_
12	shares	share	NNS	_	13	nsubj	13:A1=PPT
13	fell	fall	VBD	pb=fall.01	0	root	_
14	on	on	IN	_	13	prep	13:AM-TMP
15	Monday	monday	NNP	_	14	pobj	_
16	,	,	,	_	13	punct	_
17	dented	dent	VBN	pb=dent.01	13	advcl	13:AM-ADV
18	by	by	IN	_	17	agent	17:A0=PAG
19	a	a	DT	_	21	det	_
20	sharp	sharp	JJ	_	21	amod	_
21	drop	drop	NN	_	18	pobj	_
22	in	in	IN	_	21	prep	_
23	pharmaceutical	pharmaceutical	JJ	p2=NN	24	amod	_
24	firm	firm	NN	p2=JJ	22	pobj	_
25	AstraZeneca	astrazeneca	NNP	_	21	npadvmod	_
26	after	after	IN	_	28	mark	_
27	it	it	PRP	_	28	nsubj	28:A0=PAG
28	rejected	reject	VBD	pb=reject.01	17	advcl	17:AM-TMP
29	rival	rival	JJ	p2=NN	30	amod	_
30	Pfizer	pfizer	NNP	_	34	poss	_
31	's	's	POS	_	30	possessive	_
32	higher	high	JJR	p2=JJ	34	amod	_
33	takeover	takeover	NN	_	34	nn	_
34	bid	bid	NN	_	28	dobj	28:A1=PPT
35	.	.	.	_	13	punct	_

1	AstraZeneca	astrazeneca	NNP	p2=FW	2	nsubj	2:A0=PAG;6:A0=PAG
2	dived	dive	VBD	pb=dive.01	0	root	_
3	11.1	0	CD	_	4	num	_
4	percent	percent	NN	_	2	dobj	2:A1=LOC
5	after	after	IN	_	2	prep	2:AM-TMP
6	turning	turn	VBG	pb=turn.05	5	pcomp	_
7	down	down	RP	p2=IN	6	prt	6:C-V
8	Pfizer	pfizer	NNP	_	11	poss	_
9	's	's	POS	_	8	possessive	_
10	55	0	CD	_	11	num	_
11	pounds	pound	NNS	_	6	dobj	6:A1=PPT
12	/	/	SYM	p2=TO	13	punct	_
13	share	share	NN	p2=VBP	14	nsubj	_
14	take	take	VB	p2=NN|pb=take.01	23	ccomp	_
15	-	-	HYPH	p2=:	14	hyph	_
16	it	it	PRP	_	14	dobj	14:A1=PPT
17	-	-	HYPH	_	14	hyph	_
18	or	or	CC	_	14	cc	_
19	-	-	HYPH	_	20	hyph	_
20	leave	leave	VB	pb=leave.01	14	conj	_
21	-	-	:	p2=HYPH	14	punct	_
22	it	it	PRP	_	23	nsubj	23:A0=PAG
23	offer	offer	VBP	p2=NN|pb=offer.01	11	rcmod	_
24	.	.	.	_	2	punct	_

1	That	that	DT	_	3	det	_
2	steep	steep	JJ	_	3	amod	_
3	decline	decline	NN	_	4	nsubj	4:A1=PPT
4	was	be	VBD	pb=be.01	0	root	_
5	the	the	DT	_	7	det	_
6	biggest	big	JJS	_	7	amod	_
7	drag	drag	NN	p2=VBP	4	attr	4:A2=PRD
8	on	on	IN	_	7	prep	_
9	the	the	DT	_	10	det	_
10	FTSE	ftse	NNP	p2=NN	8	pobj	_
11	100	0	CD	_	10	num	_
12	by	by	IN	_	7	prep	_
13	some	some	DT	_	14	det	_
14	margin	margin	NN	_	12	pobj	_
15	,	,	,	_	4	punct	_
16	with	with	IN	_	4	prep	4:AM-ADV
17	the	the	DT	_	18	det	_
18	index	index	NN	_	19	nsubj	19:A1=PPT
19	closing	close	VBG	p2=NN|pb=close.02	16	pcomp	_
20	down	down	RB	p2=IN	19	advmod	19:AM-MNR
21	11.26	0	CD	_	22	num	_
22	points	point	NNS	_	20	npadvmod	_
23	,	,	,	_	22	punct	_
24	or	or	CC	_	22	cc	_
25	0.2	0	CD	_	26	num	_
26	percent	percent	NN	_	22	conj	_
27	,	,	,	_	26	punct	_
28	at	at	IN	_	19	prep	19:AM-EXT
29	6,844.55	0	CD	_	30	num	_
30	points	point	NNS	_	28	pobj	_
31	.	.	.	_	4	punct	_

1	AstraZeneca	astrazeneca	NNP	_	3	nsubj	3:A1
2	had	have	VBD	_	3	aux	_
3	risen	rise	VBN	pb=rise.01	0	root	_
4	more	more	JJR	_	6	amod	_
5	than	than	IN	_	6	quantmod	_
6	27	0	CD	_	7	num	_
7	percent	percent	NN	_	3	npadvmod	3:A2=EXT
8	in	in	IN	_	3	prep	3:AM-TMP
9	the	the	DT	_	10	det	_
10	month	month	NN	_	8	pobj	_
11	since	since	IN	_	17	mark	_
12	the	the	DT	_	15	det	_
13	first	#ord#	JJ	_	15	amod	_
14	Pfizer	pfizer	NNP	_	15	nn	_
15	bid	bid	NN	_	17	nsubjpass	17:A1
16	was	be	VBD	_	17	auxpass	_
17	reported	report	VBN	pb=report.01	3	advcl	3:AM-CAU
18	,	,	,	_	17	punct	_
19	and	and	CC	_	17	cc	_
20	traders	trader	NNS	_	21	nsubj	21:A0
21	said	say	VBD	pb=say.01	17	conj	_
22	that	that	IN	_	25	complm	_
23	a	a	DT	_	24	det	_
24	deal	deal	NN	_	25	nsubj	25:A1=PPT
25	was	be	VBD	pb=be.01	21	ccomp	21:A1=PPT
26	now	now	RB	_	25	advmod	25:AM-TMP
27	unlikely	unlikely	JJ	_	25	acomp	25:A2=PRD
28	after	after	IN	_	30	mark	_
29	Pfizer	pfizer	NNP	_	30	nsubj	33:A0=PAG
30	appeared	appear	VBD	pb=appear.02	25	advcl	25:AM-TMP
31	reluctant	reluctant	JJ	_	30	oprd	30:A1=PPT
32	to	to	TO	_	33	aux	_
33	engage	engage	VB	pb=engage.01	31	xcomp	_
34	in	in	IN	_	33	prep	33:A2=PPT
35	a	a	DT	_	37	det	_
36	hostile	hostile	JJ	_	37	amod	_
37	approach	approach	NN	_	34	pobj	_
38	.	.	.	_	21	punct	_

1	"	"	``	p2=''	29	punct	_
2	With	with	IN	_	29	prep	_
3	Pfizer	pfizer	NNP	p2=NN	4	nsubj	4:A0
4	saying	say	VBG	pb=say.01	2	pcomp	_
5	they	they	PRP	_	8	nsubj	8:A1=PPT
6	wo	wo	MD	_	8	aux	8:AM-MOD
7	n't	not	RB	_	8	neg	8:AM-NEG
8	go	go	VB	pb=go.08	4	ccomp	4:A1=PPT
9	hostile	hostile	JJ	_	8	acomp	8:A2=PRD
10	,	,	,	_	12	punct	_
11	it	it	PRP	_	12	nsubj	12:A0=PAG
12	looks	look	VBZ	pb=look.02	29	ccomp	29:A1=PPT
13	like	like	IN	_	15	mark	_
14	it	it	PRP	_	15	nsubj	15:A1=PPT
15	is	be	VBZ	pb=be.01	12	advcl	12:A1=PPT
16	pretty	pretty	RB	_	17	advmod	_
17	much	much	RB	_	18	advmod	_
18	dead	dead	JJ	_	15	acomp	15:A2=PRD
19	,	,	,	_	29	punct	_
20	"	"	''	p2=``	29	punct	_
21	Will	will	MD	p2=NNP	22	nn	_
22	Hedden	hedden	NNP	p2=VB	29	nsubj	29:A0
23	,	,	,	_	22	punct	_
24	sales	sale	NNS	_	25	nn	_
25	trader	trader	NN	_	22	appos	_
26	at	at	IN	_	25	prep	_
27	IG	ig	NNP	_	26	pobj	_
28	,	,	,	_	22	punct	_
29	said	say	VBD	pb=say.01	0	root	_
30	.	.	.	_	29	punct	_

1	"	"	``	_	16	punct	_
2	The	the	DT	_	3	det	_
3	rhetoric	rhetoric	NN	_	16	nsubj	16:A1=PPT
4	from	from	IN	_	3	prep	_
5	certain	certain	JJ	_	7	amod	_
6	government	government	NN	_	7	nn	_
7	sections	section	NNS	_	4	pobj	_
8	about	about	IN	_	7	prep	_
9	securing	secure	VBG	pb=secure.01	8	pcomp	_
10	jobs	job	NNS	_	9	dobj	9:A1=PPT
11	in	in	IN	_	10	prep	_
12	the	the	DT	_	13	det	_
13	UK	uk	NNP	_	11	pobj	_
14	will	will	MD	_	16	aux	16:AM-MOD;21:AM-MOD
15	have	have	VB	_	16	aux	_
16	been	be	VBN	pb=be.01	0	root	_
17	a	a	DT	_	18	det	_
18	hurdle	hurdle	NN	_	16	attr	16:A2=PRD
19	and	and	CC	_	16	cc	_
20	certainly	certainly	RB	_	21	advmod	21:AM-ADV
21	put	put	VBD	p2=VB|pb=put.01	16	conj	_
22	off	off	RP	_	21	prt	21:C-V
23	AstraZeneca	astrazeneca	NNP	_	24	nn	_
24	shareholders	shareholder	NNS	_	21	dobj	21:A1=PPT
25	.	.	.	_	16	punct	_
26	"	"	''	_	16	punct	_

1	Recent	recent	JJ	_	3	amod	_
2	price	price	NN	_	3	nn	_
3	moves	move	NNS	_	5	nsubj	5:A0
4	had	have	VBD	_	5	aux	_
5	left	leave	VBN	pb=leave.01	0	root	_
6	AstraZeneca	astrazeneca	NNP	_	7	nn	_
7	trading	trading	NN	p2=VBG	5	dobj	5:A1=DIR
8	at	at	IN	_	5	prep	5:AM-LOC
9	a	a	DT	_	14	det	_
10	forward	forward	JJ	p2=RB	14	amod	_
11	price	price	NN	_	13	nn	_
12	/	/	SYM	p2=,	13	punct	_
13	EPS	eps	NNP	p2=NNS	14	nn	_
14	multiple	multiple	NN	p2=JJ	8	pobj	_
15	of	of	IN	_	14	prep	_
16	19.5	0	CD	_	15	pobj	_
17	,	,	,	_	5	punct	_
18	according	accord	VBG	_	5	prep	5:AM-ADV
19	to	to	IN	_	18	prep	_
20	StarMine	starmine	NNP	p2=NN	21	nn	_
21	data	datum	NNS	p2=NNP	19	pobj	_
22	,	,	,	_	5	punct	_
23	compared	compare	VBN	_	5	prep	5:AM-ADV
24	to	to	IN	_	23	prep	_
25	15.5	0	CD	_	24	pobj	_
26	for	for	IN	_	25	prep	_
27	GlaxoSmithKline	glaxosmithkline	NNP	p2=NN	26	pobj	_
28	and	and	CC	_	25	cc	_
29	14.3	0	CD	_	25	conj	_
30	for	for	IN	_	29	prep	_
31	Sanofi	sanofi	NNP	_	30	pobj	_
32	,	,	,	_	5	punct	_
33	and	and	CC	_	5	cc	_
34	over	over	RB	p2=IN	35	advmod	_
35	double	double	PDT	p2=JJ	40	num	_
36	its	its	PRP$	_	40	poss	_
37	10	0	CD	_	39	hmod	_
38	-	-	HYPH	_	39	hyph	_
39	year	year	NN	_	40	nn	_
40	median	median	NN	p2=NNS	5	conj	_
41	of	of	IN	_	40	prep	_
42	9.3	0	CD	_	41	pobj	_
43	.	.	.	_	5	punct	_

1	But	but	CC	_	12	cc	12:AM-DIS
2	following	follow	VBG	_	12	prep	12:AM-TMP
3	Monday	monday	NNP	_	9	poss	_
4	's	's	POS	_	3	possessive	_
5	share	share	NN	_	6	nn	_
6	price	price	NN	_	9	nn	_
7	pull	pull	NN	p2=VB	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	back	back	NN	_	2	pobj	_
10	,	,	,	_	12	punct	_
11	Citi	citi	NNP	_	12	nsubj	12:A0;16:A0=PAG
12	took	take	VBD	pb=take.01	0	root	_
13	the	the	DT	_	14	det	_
14	opportunity	opportunity	NN	_	12	dobj	12:A1=PPT
15	to	to	TO	_	16	aux	_
16	add	add	VB	pb=add.02	14	infmod	_
17	AstraZeneca	astrazeneca	NNP	_	16	dobj	16:A1=PPT
18	to	to	IN	_	16	prep	16:A2=PPT
19	its	its	PRP$	_	22	poss	_
20	Focus	focus	NNP	_	21	nn	_
21	List	list	NNP	_	22	nn	_
22	Europe	europe	NNP	_	18	pobj	_
23	.	.	.	_	12	punct	_

1	It	it	PRP	_	2	nsubj	2:A0=PAG
2	reckoned	reckon	VBD	pb=reckon.01	0	root	_
3	the	the	DT	_	4	det	_
4	market	market	NN	_	8	nsubj	_
5	still	still	RB	_	8	advmod	_
6	under	under	RB	p2=IN	8	hmod	_
7	-	-	HYPH	p2=,	8	hyph	_
8	appreciated	appreciate	VBN	p2=VBD	2	ccomp	2:A1=PPT
9	AstraZeneca	astrazeneca	NNP	_	11	poss	_
10	's	's	POS	_	9	possessive	_
11	portfolio	portfolio	NN	_	8	dobj	_
12	in	in	IN	_	8	prep	_
13	both	both	DT	p2=CC	16	preconj	_
14	immune	immune	JJ	p2=RB	16	hmod	_
15	-	-	HYPH	_	16	hyph	_
16	oncology	oncology	NN	_	12	pobj	_
17	and	and	CC	_	16	cc	_
18	the	the	DT	_	19	det	_
19	management	management	NN	_	16	conj	_
20	of	of	IN	_	19	prep	_
21	auto	auto	NN	_	23	hmod	_
22	-	-	HYPH	_	23	hyph	_
23	immune	immune	JJ	p2=NN	25	amod	_
24	related	relate	VBN	p2=JJ|pb=relate.01	25	amod	_
25	disease	disease	NN	_	20	pobj	24:A1=PPT
26	.	.	.	_	2	punct	_

1	The	the	DT	_	2	det	_
2	FTSE	ftse	NNP	p2=NN	4	nsubj	4:A0=PAG
3	100	0	CD	p2=NNP	2	num	_
4	retraced	retrace	VBD	pb=retrace.01	0	root	_
5	some	some	DT	_	4	dobj	4:A1=PPT
6	of	of	IN	_	5	prep	_
7	the	the	DT	_	9	det	_
8	previous	previous	JJ	_	9	amod	_
9	week	week	NN	_	13	poss	_
10	's	's	POS	_	9	possessive	_
11	0.6	0	CD	_	12	num	_
12	percent	percent	NN	p2=JJ	13	nn	_
13	gain	gain	NN	_	6	pobj	16:A0
14	,	,	,	_	13	punct	_
15	which	which	WDT	_	16	nsubj	16:R-A0
16	saw	see	VBD	pb=see.01	13	rcmod	_
17	it	it	PRP	_	18	nsubj	18:A0=PAG
18	touch	touch	VB	p2=JJ|pb=touch.01	16	ccomp	16:A1
19	14	0	CD	_	21	hmod	_
20	-	-	HYPH	_	21	hyph	_
21	year	year	NN	_	22	nn	_
22	highs	high	NNS	_	18	dobj	18:A1=PPT
23	.	.	.	_	4	punct	_

1	On	on	IN	_	4	prep	4:AM-TMP
2	Thursday	thursday	NNP	_	1	pobj	_
3	it	it	PRP	_	4	nsubj	4:A1=PPT
4	came	come	VBD	pb=come.04	0	root	_
5	within	within	IN	_	4	prep	4:AM-PRD
6	0.8	0	CD	_	7	num	_
7	percent	percent	NN	_	5	pobj	_
8	of	of	IN	_	7	prep	_
9	all	all	DT	_	11	hmod	_
10	-	-	HYPH	_	11	hyph	_
11	time	time	NN	_	12	nn	_
12	highs	high	NNS	_	8	pobj	13:A1=PPT
13	set	set	VBN	pb=set.01	12	partmod	_
14	in	in	IN	_	13	prep	13:AM-TMP
15	December	december	NNP	_	14	pobj	_
16	1999	0	CD	p2=NNP	15	num	_
17	.	.	.	_	4	punct	_

1	"	"	``	p2=''	20	punct	_
2	With	with	IN	_	20	prep	20:AM-ADV
3	the	the	DT	_	4	det	_
4	FTSE	ftse	NNP	p2=NN	2	pobj	_
5	100	0	CD	p2=NNP	4	num	_
6	close	close	RB	p2=NN	4	advmod	_
7	to	to	IN	_	6	prep	_
8	all	all	DT	p2=JJ	10	hmod	_
9	-	-	HYPH	_	10	hyph	_
10	time	time	NN	_	12	hmod	_
11	-	-	HYPH	p2=:	12	hyph	_
12	high	high	JJ	_	13	amod	_
13	territory	territory	NN	_	7	pobj	_
14	,	,	,	_	20	punct	_
15	concerns	concern	NNS	_	20	nsubjpass	20:A1=PPT
16	have	have	VBP	_	20	aux	_
17	once	once	RB	_	18	advmod	_
18	again	again	RB	_	20	advmod	20:AM-TMP
19	been	be	VBN	_	20	auxpass	_
20	raised	raise	VBN	pb=raise.01	35	ccomp	35:A1=PPT
21	in	in	IN	_	20	prep	20:AM-LOC
22	relation	relation	NN	_	21	pobj	_
23	to	to	IN	_	22	prep	_
24	valuation	valuation	NN	p2=NNP	23	pobj	_
25	,	,	,	_	20	punct	_
26	which	which	WDT	_	28	nsubj	28:R-A0
27	is	be	VBZ	_	28	aux	_
28	creating	create	VBG	pb=create.01	20	advcl	20:AM-ADV
29	something	something	NN	_	28	dobj	28:A1=PPT
30	of	of	IN	_	29	prep	_
31	a	a	DT	_	32	det	_
32	headwind	headwind	NN	p2=RB	30	pobj	_
33	,	,	,	_	35	punct	_
34	"	"	''	_	35	punct	_
35	said	say	VBD	pb=say.01	0	root	_
36	Jeremy	jeremy	NNP	_	39	nn	_
37	Batstone	batstone	NNP	_	39	hmod	_
38	-	-	HYPH	_	39	hyph	_
39	Carr	carr	NNP	_	35	nsubj	35:A0
40	,	,	,	_	39	punct	_
41	analyst	analyst	NN	_	39	appos	_
42	at	at	IN	_	41	prep	_
43	Charles	charles	NNP	_	44	nn	_
44	Stanley	stanley	NNP	_	42	pobj	_
45	.	.	.	_	35	punct	_

1	In	in	IN	_	11	prep	11:AM-LOC
2	common	common	JJ	p2=NN	1	amod	_
3	with	with	IN	_	2	prep	_
4	AstraZeneca	astrazeneca	NNP	_	3	pobj	_
5	,	,	,	_	11	punct	_
6	the	the	DT	_	8	det	_
7	broader	broad	JJR	_	8	amod	_
8	market	market	NN	_	11	nsubj	11:A1=PPT
9	is	be	VBZ	_	11	aux	_
10	also	also	RB	_	11	advmod	11:AM-DIS
11	trading	trade	VBG	p2=NN|pb=trade.01	0	root	_
12	above	above	IN	p2=RB	11	prep	11:AM-LOC
13	long	long	JJ	p2=RB	15	hmod	_
14	-	-	HYPH	_	15	hyph	_
15	run	run	NN	p2=VBN	17	nn	_
16	average	average	JJ	p2=NN	17	amod	_
17	valuations	valuation	NNS	_	12	pobj	_
18	.	.	.	_	11	punct	_

1	The	the	DT	_	4	det	_
2	FTSE	ftse	NNP	p2=JJ	4	nn	_
3	100	0	CD	p2=NNP	2	num	_
4	trades	trade	NNS	_	0	root	27:A1=PPT
5	at	at	IN	_	4	prep	_
6	a	a	DT	_	7	det	_
7	price	price	NN	_	5	pobj	_
8	to	to	IN	p2=TO	4	prep	_
9	earnings	earnings	NNS	_	10	nn	_
10	ratio	ratio	NN	_	8	pobj	_
11	of	of	IN	_	10	prep	_
12	13.8	0	CD	_	11	pobj	_
13	,	,	,	_	4	punct	_
14	compared	compare	VBN	_	4	prep	_
15	to	to	IN	_	14	prep	_
16	a	a	DT	_	20	det	_
17	10	0	CD	_	19	hmod	_
18	-	-	HYPH	_	19	hyph	_
19	year	year	NN	_	20	nn	_
20	average	average	NN	_	15	pobj	_
21	of	of	IN	_	20	prep	_
22	11.8	0	CD	_	21	pobj	_
23	,	,	,	_	27	punct	_
24	Thomson	thomson	NNP	_	26	nn	_
25	Reuters	reuters	NNP	_	26	nn	_
26	Datastream	datastream	NNP	_	27	nsubj	27:A0=CAU
27	showed	show	VBD	pb=show.01	0	root	_
28	.	.	.	_	27	punct	_

1	The	the	DT	_	4	det	_
2	top	top	JJ	_	4	amod	_
3	two	#crd#	CD	_	4	num	_
4	risers	riser	NNS	_	5	nsubj	5:A1=PPT
5	were	be	VBD	pb=be.01	0	root	_
6	airlines	airline	NNS	_	7	nn	_
7	easyJet	easyjet	NNS	p2=RB	5	attr	5:A2=PRD
8	,	,	,	_	7	punct	_
9	up	up	RB	_	7	advmod	_
10	4.7	0	CD	_	11	num	_
11	percent	percent	NN	_	9	npadvmod	_
12	,	,	,	_	7	punct	_
13	and	and	CC	_	7	cc	_
14	International	international	NNP	p2=JJ	16	nn	_
15	Consolidated	consolidated	NNP	_	16	nn	_
16	Airlines	airline	NNPS	p2=NNP	7	conj	_
17	,	,	,	_	16	punct	_
18	up	up	RB	p2=RP	16	advmod	_
19	3.5	0	CD	_	20	num	_
20	percent	percent	NN	_	18	npadvmod	_
21	,	,	,	_	16	punct	_
22	as	as	IN	_	31	prep	31:AM-CAU
23	forecast	forecast	NN	p2=VBN	25	hmod	_
24	-	-	HYPH	_	25	hyph	_
25	beating	beat	VBG	p2=NN	26	amod	_
26	results	result	NNS	_	22	pobj	_
27	from	from	IN	_	26	prep	_
28	Irish	irish	JJ	_	29	amod	_
29	peer	peer	NN	_	30	nn	_
30	Ryanair	ryanair	NNP	_	27	pobj	_
31	buoyed	buoy	VBD	pb=buoy.01	5	advcl	_
32	the	the	DT	_	33	det	_
33	sector	sector	NN	_	31	dobj	31:A1=PPT
34	.	.	.	_	5	punct	_

1	This	this	DT	_	2	det	_
2	discussion	discussion	NN	_	5	nsubjpass	5:A1=PPT
3	is	be	VBZ	_	5	auxpass	_
4	now	now	RB	_	5	advmod	5:AM-TMP
5	closed	close	VBN	p2=JJ|pb=close.01	0	root	_
6	.	.	.	_	5	punct	_

1	We	we	PRP	_	2	nsubj	2:A0=PAG
2	welcome	welcome	VBP	pb=welcome.01	0	root	_
3	comments	comment	NNS	_	2	dobj	2:A1=PPT
4	on	on	IN	_	3	prep	_
5	our	our	PRP$	_	6	poss	_
6	articles	article	NNS	_	4	pobj	_
7	for	for	IN	_	6	prep	_
8	a	a	DT	_	10	det	_
9	limited	limited	JJ	_	10	amod	_
10	period	period	NN	_	7	pobj	_
11	after	after	IN	_	10	prep	_
12	their	their	PRP$	_	13	poss	_
13	publication	publication	NN	_	11	pobj	_
14	.	.	.	_	2	punct	_

